Clinical Trial

Multiple Risk Factor Intervention Trial in Breast Cancer Survivors

Study acronym: MsFITBC
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to produce new evidence on the efficacy of exercise and diet for cardiometabolic risk reduction in BC survivors. Using a 3-arm RCT with to 6 months of 1) exercise following Health Canada guidelines; 2) the same exercise plus counselling to follow Canada's Dietary Guidelines to improve diet quality; or 3) stretching group, this study will answer the following questions: * What is the impact of exercise on cardiometabolic health and body composition in BC survivors? * What is the effect modification of adding a diet quality intervention to exercise on cardiometabolic health and body composition? * Is there a link between the capacity of skeletal muscle adaptation to exercise (and diet) and insulin resistance in BC survivors? The investigators hypothesize that: 1) exercise will improve cardiometabolic and body composition outcomes 2) improvements in cardiometabolic outcomes will be enhanced by the addition of diet quality, which will be essential or additive for Matsuda index, metabolic syndrome, Framingham CVD risk, thigh myosteatosis, muscle mass, VO2peak, 3) skeletal muscle insulin signalling transduction will be impaired in BC survivors via dampened expression of insulin-responsive proteins (e.g. GLUT4) and co-occur with impaired muscle quality (e.g., higher rates of fat depots, presence of fibrous tissue) negatively impacting insulin signalling.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-06; most recent amendment 2025-09-26.
Status change: Not Yet Recruiting → Recruiting 2025-09-26
Trial Details
NCT Number NCT06454864
Lead Sponsor University of Toronto
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions Metabolic Disturbance, Sedentary Behavior, Breast Cancer Female
Enrollment 45 participants
Start Date 2024-07-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-01